Study to Select the Dose and Evaluate Safety and Efficacy of Monoclonal Antibody in Adult With Recently Diagnosed Asymptomatic to Moderately Severe COVID-19.

NCT04952805 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

800

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid19

Interventions

DRUG: MAD0004J08
OTHER: Placebo

Sponsor

Toscana Life Sciences Sviluppo s.r.l.